X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (160) 160
index medicus (137) 137
hematology (128) 128
oncology (103) 103
aged (90) 90
male (88) 88
female (87) 87
middle aged (85) 85
multiple myeloma (77) 77
bortezomib (69) 69
aged, 80 and over (64) 64
adult (63) 63
treatment outcome (52) 52
multiple myeloma - drug therapy (51) 51
prognosis (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
survival (41) 41
dexamethasone (37) 37
cancer (36) 36
multiple-myeloma (35) 35
stem-cell transplantation (35) 35
lenalidomide (31) 31
hematology, oncology and palliative medicine (30) 30
thalidomide (30) 30
antineoplastic agents - therapeutic use (26) 26
chemotherapy (25) 25
therapy (23) 23
multiple myeloma - complications (22) 22
survival analysis (21) 21
thalidomide - analogs & derivatives (21) 21
care and treatment (20) 20
multiple myeloma - mortality (20) 20
multiple myeloma - diagnosis (19) 19
abridged index medicus (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
consensus panel recommendations (17) 17
multiple myeloma - pathology (17) 17
rituximab (17) 17
combination (16) 16
waldenstrom macroglobulinemia - drug therapy (16) 16
amyloidosis (15) 15
dexamethasone - administration & dosage (15) 15
monoclonal gammopathy (15) 15
survival rate (15) 15
analysis (14) 14
dexamethasone - therapeutic use (14) 14
neoplasm staging (14) 14
patient outcomes (14) 14
retrospective studies (14) 14
2nd international workshop (13) 13
biomarkers (13) 13
boronic acids - therapeutic use (13) 13
diagnosis (13) 13
disease-free survival (13) 13
medical research (13) 13
multivariate analysis (13) 13
myeloma (13) 13
pharmacology & pharmacy (13) 13
pyrazines - therapeutic use (13) 13
risk factors (13) 13
thalidomide - administration & dosage (13) 13
disease (12) 12
expression (12) 12
follow-up studies (12) 12
multiple myeloma - therapy (12) 12
thalidomide - therapeutic use (12) 12
al amyloidosis (11) 11
antineoplastic agents - adverse effects (11) 11
boronic acids - administration & dosage (11) 11
carfilzomib (11) 11
disease progression (11) 11
drug therapy (11) 11
light-chain amyloidosis (11) 11
medical colleges (11) 11
medical prognosis (11) 11
melphalan (11) 11
multiple myeloma - blood (11) 11
plus dexamethasone (11) 11
pyrazines - administration & dosage (11) 11
refractory multiple-myeloma (11) 11
thalidomide - adverse effects (11) 11
waldenstrom macroglobulinemia - pathology (11) 11
zoledronic acid (11) 11
angiogenesis (10) 10
article (10) 10
kaplan-meier estimate (10) 10
patients (10) 10
phase-ii (10) 10
recurrence (10) 10
waldenstrom macroglobulinemia - diagnosis (10) 10
waldenstrom macroglobulinemia - therapy (10) 10
age factors (9) 9
antibodies, monoclonal - therapeutic use (9) 9
biopsy (9) 9
cyclophosphamide - administration & dosage (9) 9
ibrutinib (9) 9
immunoglobulin light chains - blood (9) 9
immunoglobulins (9) 9
immunologic factors - therapeutic use (9) 9
life sciences (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Blood, ISSN 0006-4971, 09/2019, p. blood.2019000725
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 03/2019, Volume 94, Issue 3, pp. 394 - 396
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 241 - 250
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2014, Volume 89, Issue 1, pp. 34 - 40
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 34, pp. 8580 - 8587
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 9, pp. 904 - 916
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 277 - 278
Journal Article